Home/Filings/4/0001011034-09-000069
4//SEC Filing

KEMPF DAVID A 4

Accession 0001011034-09-000069

CIK 0001443062other

Filed

Jun 18, 8:00 PM ET

Accepted

Jun 19, 5:32 PM ET

Size

14.2 KB

Accession

0001011034-09-000069

Insider Transaction Report

Form 4
Period: 2009-06-17
KEMPF DAVID A
DirectorCOO/CFO
Transactions
  • Purchase

    Series A Convertible Preferred Stock

    2009-06-17$1.00/sh+7,500$7,500316,667 total
    Exercise: $0.75From: 2009-06-17common stock (10,000 underlying)
  • Purchase

    warrants

    2009-06-17+3,750320,417 total
    Exercise: $1.50From: 2009-06-17Exp: 2010-12-17common stock (3,750 underlying)
Holdings
  • Common Stock

    (indirect: By IRA)
    2,800
  • options

    Exercise: $1.00From: 2012-02-11Exp: 2019-02-11common stock (100,000 underlying)
    300,000
  • Options

    Exercise: $1.00From: 2010-02-11Exp: 2019-02-11Common Stock (100,000 underlying)
    100,000
  • Options

    Exercise: $1.00From: 2011-02-11Exp: 2019-02-11common stock (100,000 underlying)
    200,000
  • Common Stock

    (indirect: By IRA)
    3,000
  • Series A Convertible Preferred Stock

    Exercise: $0.75From: 2009-04-15common stock (6,667 underlying)
    306,667
Footnotes (1)
  • [F1]not applicable

Issuer

BIOMEDICAL TECHNOLOGY SOLUTIONS HOLDINGS INC

CIK 0001443062

Entity typeother

Related Parties

1
  • filerCIK 0001458510

Filing Metadata

Form type
4
Filed
Jun 18, 8:00 PM ET
Accepted
Jun 19, 5:32 PM ET
Size
14.2 KB